Abstract
Transcarotid artery revascularization (TCAR) requires participation in the Vascular Quality Initiative (VQI) and is subject to increased scrutiny of preoperative medications from industry representatives, which is absent in transfemoral carotid artery stenting (tfCAS) and carotid endarterectomy (CEA). The goal of this project is to determine if optimal preoperative medical therapy for stenting (sOMT: statin and P2Y12-inhibitor therapy) is disparate for these procedures in the VQI, and assess the impact on perioperative outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
